Pacific Biosciences Of California (PACB) Net Margin Growth (1y) (2011 - 2026)
Pacific Biosciences Of California (PACB) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 67.00 |
| 10 | Pacific Biosciences Of California | 419.38 Mn | 182.51 Mn | 12.64 Mn | -926.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -926.00 |
| Mar 31, 2026 | 112,455.00 |
| Dec 31, 2025 | -9,647.00 |
| Sep 30, 2025 | 5,309.00 |
| Jun 30, 2025 | 37,583.00 |
| Mar 31, 2025 | -94,537.00 |
| Dec 31, 2024 | 14,659.00 |
| Sep 30, 2024 | -3,187.00 |
| Jun 30, 2024 | -33,448.00 |
| Mar 31, 2024 | 2,482.00 |
| Dec 31, 2023 | 16,795.00 |
| Sep 30, 2023 | 11,815.00 |
| Jun 30, 2023 | 5,451.00 |
| Mar 31, 2023 | 1,942.00 |
| Dec 31, 2022 | -11,602.00 |
| Jun 30, 2022 | 8,680.00 |
| Mar 31, 2022 | -11,451.00 |
| Dec 31, 2021 | -46,863.00 |
| Jun 30, 2021 | 18,723.00 |
| Mar 31, 2021 | 8,450.00 |